Methenamine, Sodium Salicylate
Methenamine, Sodium Salicylate · METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 · Tablet · Amol Pharmaceuticals Private Limited
NDC 63189-0022-24 · 135 BLISTER PACK in 1 CASE / 24 TABLET in 1 BLISTER PACK · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market · price up 5% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Methenamine, Sodium Salicylate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Clarion Brands, LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| AmerisourceBergen Drug Corp | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amol Pharmaceuticals Private Limited | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amol Pharmaceuticals Private Limited | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cadence Health, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Consortium, LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| i-Health, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Meijer Distribution Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nuvicare Llc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Pioneer Life Sciences, Llc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Reese Pharmaceutical Co | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rite Aid | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Marketing Association | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| CVS Pharmacy, Inc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
| Walgreen Company | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Methenamine, Sodium Salicylate — NDC 63189-0022-24," retrieved September 3, 2026, https://drugdashboards.com/drug/63189002224.
Free to cite with attribution — see how the data is put together.